Net Cash Provided by (Used in) Operating Activities |
-560K |
USD |
-139% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
525K |
USD |
+75% |
Q1 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-393K |
USD |
|
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
200M |
shares |
+100% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
22.7M |
shares |
+1212% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
569K |
USD |
-89.2% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
13.7M |
USD |
|
Q3 2024 |
Q3 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
1M |
USD |
|
Q1 2023 |
Q1 2023 |
Depreciation |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-10.6M |
USD |
-521% |
Q3 2024 |
Q3 2024 |
Property, Plant and Equipment, Gross |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
13.7M |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Deferred Federal Income Tax Expense (Benefit) |
115K |
USD |
-56.4% |
Q1 2023 |
Q1 2023 |
Preferred Stock, Shares Authorized |
100M |
shares |
+9900% |
Q3 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
46.4M |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Current Federal Tax Expense (Benefit) |
24K |
USD |
|
Q1 2023 |
Q1 2023 |
Amortization of Intangible Assets |
378K |
USD |
0% |
Q1 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |